Development of Brain Shuttle Enabled AT-04, a Novel Peptibody That Binds Neuropathologic Fibrillar Aggregates

S. Selvarajah¹, P. Stocki², A. Vick¹, M. Klein¹, N. Angell¹, A. Gauhar², S. Coker², J. S. Foster³, S. Macy³, A. Williams³, M. Balachandran³, L.J. Rutkowski², J. Wall³

¹Attralus Inc, San Francisco, California, USA

²Ossianix Inc, Stevenage, UK

³University of Tennessee Graduate School of Medicine, USA